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PROGNOSIS OF 
ANGINA PECTORIS
Christian F . B orchgrevin k
From: Department VII, Ulleval sykehus Head: Professor dr. med. Einar M. Blegen
C o ron ary  heart disease expresses itself usually 
as angina pectoris o r m yocardial infarction. A t  
least in  N o rw ay, an gin a  pectoris is the m ore com ­
m on form , p articu larly  in people under the age 
o f  65. T h e  vast m ajority  o f  patients w ith  m yo­
cardial infarction is adm itted  to hospitals w hile 
the m ajority  o f  patients w ith  angina pectoris as 
the sole expression o f  coron ary heart disease seeks 
a general practition er i f  he sees a  doctor a t all. 
Therefore the incidence o f  angina pectoris in the 
population  is less w ell know n, than the incidence 
o f  m yocardial infarction and consequently the 
exact prognosis is hard  to give.
T h e  large  A m erican  studies on the prognosis 
o f  angina pectoris include a  h igh  p ercen tage o f  
patients w ho have experienced one or m ore in ­
farctions, w ho have developed heart failure or w ho 
have card iac enlargem ent. T h e  prognosis in  such 
patients is therefore un likely to be the sam e as in 
patients w ith , so far, un com plicated  angina 
pectoris.
A lth o u gh  sudden death or an  acute infarction 
w ill a lw ays h an g as a  D am ocles sword over the 
heads o f  patients w ith  angina pectoris (as it 
actu ally  does over the heads o f  all o f  us) the 
prognosis is p ro b ab ly  not as grave  as gen era lly  
accepted 30 years ago. P au l D . W h ite  states in 
one o f  his m an y papers that the average survival 
w as thought to be less than 5 years. S u ch  figures 
w ere usually derived from  autopsy data. Z o ll et al. 
( 19 5 1) found am ong 177 autopsied patients w ith  
angina pectoris that 1/3 h ad  died w ithin one year 
after start o f  sym ptom s, 50 per cent w ith in  2 
years, 75 per cen t w ith in  5 years and  90 per cent 
w ithin 10 years. T o  m e such figures only show 
that some patients die soon after developing 
angina pectoris an d  th a t some patients live for a 
lon g tim e. B u t as w e do not know  the n um ber o f  
liv in g  patients w ith  angina, the figures tell very 
little  abou t the exact prognosis.
A s the results o f  the long-term  studies, m ainly 
from  A m erica, appeared, it was clearly  shown 
that the prognosis alth ough still grave, w as at 
least som ew hat brighter than gen era lly  felt. In  
1943 W h ite  et al. published their experience w ith 
500 patients w ith  angina pectoris, follow ed for 
alm ost 20 years, and in 1956 R ich ard  et al. p u b - 
lished a follow -up study. T h is  is a  rem arkable 
study as all patients w ere traced, the sam e can 
un fortun ately  not be said a b ou t the other large 
A m erican  studies. T h e  survival curve is show n in 
F igure  1. H a lf  o f  the patients w ere dead years 
after diagnosis w as m ade. Som e patients were 
still a live  30 years after diagnosis. O n ly  20 per cent 
o f  the patients had norm al card iac status at the 
tim e o f  diagnosis, and they show ed a  better prog­
nosis as the group  as a  w hole, a  poin t I shall return 
to. 76 per cent o f  all the deaths w ere cardiac.
T h e  largest study was published b y  B lock et al. 
in 1952. A lm ost 7,000 patients w ere follow ed from 
5 to 23 years. T h e  average duration  o f  angina 
pectoris prior to diagnosis was 2 1/2 years and 25 per 
cent o f  the patients had experienced previous 
infarction.
Figure 2 shows the survival curve o f  the patients 
together w ith  the corresponding curve o f  the 
norm al population. It  w ill be seen that there was a 
distinct higher m ortality the first year after 
diagnosis. T h e  5 and 10 years’ survival were 58.4 
and 37.1 per cent respectively against 86.9 and 
70.4 in the norm al population. A lm ost 20 per cent 
o f  the patients could not be traced after 10 years.
T a b le  1 on p age 56 shows that the survival rate 
falls w ith  age. H ow ever, w hen adjusted for n or­
m al death, the effect o f  angina survival is the sam e 
in all on age groups. A  sim ilar observation was 
m ade by W h ite  el al., i.e. th at the excess m ortality  
o f  patients w ith  angina pectoris m easured in 
num bers o f  lives is independent o f  age.
T h e  study o f  Block el al. gives detailed inform ation
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F IG . I Years after diagnosis (W hite el al. 1943)
F IG . 2 Years after diagnosis (Block et al. 1952)
on factors influencing the prognosis as shown in 
T ab le  2. Patients with hypertension, abnormal 
E G G , cardiac enlargement or previous myocardial 
infarction have a more serious prognosis while 
angina pectoris connected with obesitas showed 
a better prognosis. T h ey  also made the observa-
tion that angina pectoris connected with m alig­
nant disease showed a poor prognosis, a statement 
I do not find unreasonable. This multifactorial 
influence on prognosis makes prognostic com­
parison from one series to another very diffi­
cult and almost meaningless, particularly when
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T a b le  i
A g e
(Years)
S u rvival R a te  in  %
5 years 
A djusted  for 
N orm al D eath
10 years 
A djusted  for 
N orm al D eath
< 4 0 66 68 47 50
40-49 65 69 43 49
50-59 61 68 37 48
60-69 55 69 29 5 1
70-79 43 72 16 62
(Block el al. 1952) 
T a b le  2
S u rvival R a te
In %
5 Y ears 10 Y ears
T o ta l Series 58 33
Previous Infarction 46 26
A b n o rm al E C G 43 23
C a rd ia c  H yp ertrop hy 41 20
H eart F ailure 20 8
H ypertension, G ro u p  3 22 I -3
N o C a rd ia c  H yp ertrop h y 
N orm al Blood Pressure
64
63
39
40
(Block el al. 1952)
evalu atin g  effects o f  drugs on the long-term  
prognosis. T h is  situation is sim ilar to the one w e are 
facin g after m yocardial infarction, w hich  w as clear­
ly pointed out b y  o u r C h airm an  som e years ago.
In 1960, Seim , from  N o rw ay, studied the p rog­
nosis o f  angina pectoris in 600 patients follow ed for 
5 to 25 years. 99 per cent could  be traced. T h e  5 
and 10 years’ survival w as ab ou t 70 and 50 per 
cent, respectively slightly better than in B lock’s 
m ateria l. F igure  3 on p age 57 shows that females 
have a  better prognosis than m ales. Patients w ith  
norm al E C G  have a  m uch better prognosis than 
patients w ith  abnorm al E C G , the 5 years’ m ortal­
ity  bein g abou t 22 and 45 per cent respectively.
T h e  problem  o f  remission has been attacked by 
R isem an (1966), w ho has follow ed 122 patients 
w ith  angina pectoris w eekly for 6 m onths to 161/2 
years. M o re  than h a lf  the patients show ed re­
missions, defined as 2 m onths or m ore w ithout 
pain. H a lf  o f  these w ere free from  pain  for m ore 
than one year. In  h a lf  the patients the remission
was spontaneous. 20 per cent o f  the patients had 
periods w ith  exacerbations. I t  w as im possible to 
beforehand to tell w hether a patient w ould ex­
perience a  remission or an exacerbation.
L ife  Insurance C om p anies’ Institute for M ed ical 
Statistics at O slo C ity  H ospitals has m ade a study 
o f  331 patients w ith  angina pectoris w ithout 
infarction. T h e  m ajority attended an out-patient 
clin ic, and the others had been adm itted  to 
m edical departm ents. T a b le  3 shows the ratio  o f  
observed/expected deaths. T h is  ratio falls w ith  age 
w hich  m ay be interpreted to m ean that angina 
pectoris is m ore serious in yo u n g patients. H o w ­
ever, i f  take the difference in the num bers o f  
deaths betw een patients and the norm al p o p u la­
tion there is actu ally  very  little d ifference betw een 
the age groups, confirm ing Block el al. ’s and 
R ich ard  et al.'s findings that the excess m ortality  
in an gin a  pectoris expressed as the n um ber o f 
deaths is independent o f  age.
T a b le  3
A ge
(Years)
N u m b er o f  Deaths
O bserved/
E xpected
D ifference Between 
Patients and 
Population  (per 1000)
35-54 5'5 30
55-69 2 3 34
> 7 0 1-4 37
T h ere  seems to be little difference in the ratio 
w hether the angina lasted a short or a  long time 
before registration (T a b le  4). T h e  duration  o f  the 
observation period seems also to have little  in ­
fluence on the excess m ortality  (T a b le  5) on page 
58. T h is  is in contrast to the result o f  B lock et al. 
w ho found a higher m ortality  in the first year. 
T h e  discrepancy m ay perhaps be explain ed by 
T a b le  6 on page 58. w hich  clearly  shows a 
h igher m ortality  the first y ea r after m yocardial 
infarction. 25 per cent o f  B lo ck ’s patients had
T a b le  4
D uration  o f  A n g in a  
Prior to R egistration
N u m ber o f  D eaths 
O bserved/E xpected
< 6  M onths 1 .6
6 -12  M onths 2-2
1-2  Y ears 1.5
2 -5  Y ears 2 .9
> 5  Y ears 2 .8
Control
+ Anticoagulant Treated
FIG . 4 Years after diagnosis
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Table 5
Number o f Deaths
Obs. Period Observed/Expected
< 6  months 2. 1
6-12 months 2.4
1-5 years 2.3
>  years 1.8
Table 6
No. of Deaths -  Observed/Expected
Age
(Years) Years after discharge from hospital
1 2-5 > 5
30-49 10.6 7 .2 4'5
50-64 6-0 3 .4 2.8
Patients with Myocardial Infarction
experienced infarction, and this fact may explain 
the high mortality in first year.
Table 7 shows that there was, perhaps sur­
prisingly, no difference in prognosis between the 
patients with moderate or severe angina pectoris 
as White el al. have also pointed out.
By carefully reading the patients’ history it 
turned out that the majority of the patients had 
angina on exertion while the minority did not, 
although they still got a diagnosis o f angina pec­
toris.
Table 7
Number of Deaths
Angina Observed/Expected
Severe 2 .2
Moderate 2 .0
Table 8 shows that only angina on exertion 
is correlated with excess mortality while the 
patients with diagnosed angina pectoris without 
this symptom actually seemed to have a mortality
lower than normal, indicating most likely that
they did in fact not have coronary heart disease.
Table 8
Angina Number of Deaths
on Exertion Observed/Expected
Yes 2.6
No 0-5
The serum cholesterol level is a well known 
predictor of myocardial infarction in normal 
persons, and Table g shows that this holds true 
also for patients with angina pectoris.
Table 9
Cholesterol
(M G %
Incidence (3 years) of 
Myocardial Infarction
No Angina 
Pectoris
With Angina 
Pectoris
<249 0-8 4 .9
250-299 1-9 8.1
>300 3 .0 20.8
Westlund & Nicolaysen 1966
May medical or surgical treatment influence 
the prognosis in patients with angina pectoris? 
As far as I know, there has been no dietary study 
on such patients. But recent experience in Norway 
where a strict cholesterol Iowering diet reduced the 
rate of re-infarction in male survivors of acute 
infarction, makes it likely that such diet also 
would be of benefit to patients with angina 
pectoris.
Most of the drugs used in the treatment of 
angina pectoris are aimed at curing or preventing 
the anginal attack. Even if this goal is achieved 
we do not know whether these drugs actually pro­
long the life o f the patients, as no large long-term 
study exists.
Several authors have reported on the long-term 
effect of surgical treatment. Hallen (1964) 
followed 90 patients employing the method of 
Beck, for 21/2 years. The annual mortality was 7 
per cent which does not permit any conclusion. 
Brofman ( 1960) observed 110 patients for 3-5 
years, of whom 75 per cent survived 5 years. He 
compared his results with the study of Block et al. 
who found a 5 year survival rate of 58.4 per cent 
and concluded that his patients had benefited 
from the operation, a conclusion hard to accept 
because of lack of information on the similarity of 
the two groups.
It is difficult for me to discuss the prognosis of 
angina pectoris without mentioning the possible 
beneficial effect of long-term anticoagulent 
therapy. In 1957 we randomized patients with 
angina pectoris without infarction with normal 
blood pressure and heart size, into an anticoagu­
lant group and a control group. After 18 months
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one death has occurred in the treated group 
against 9 in the control group, a difference 
statistically significant at the 1 per cent level. I 
made a follow-up study last month and the 
Figure 4 shows the result. A ll patients are traced 
and followed for a minimum o f 71/2 years and a 
maximum o f 91/2 years or until death. 80 per cent 
o f the survivors are still on anticoagulant therapy. 
T he 5 year survival in the anticoagulant treated 
group was 93.2 per cent, which is definitely higher 
than in any report in the literature and statisti­
cally significantly higher than in the control 
group where the survival was 77 per cent. Beyond 
the first years the interpretation o f the curves is 
difficult and comparison between them is o f little 
meaning. Anticoagulant therapy was started in 
the control group 1 1/2 to 2 years after the start o f 
the study as we did not feel justified in withholding 
this therapy from the patients. T h e 10 year 
survival rate was the same in the two groups (75 
per cent) but now we have no control group for 
comparison. I would guess that M r. Chairman 
would disagree with me, but I still think that the 
most likely interpretation o f these results is that 
anticoagulant therapy is o f value in patients with 
angina pectoris when given within a year after 
the first symptoms.
Conclusion
H ow is one to conclude? T h e prognosis o f 
angina pectoris is as unpredictable as life itself. 
Some patients die soon after their first attack, 
some go on living almost for ever. It  is extremely 
difficult i f  not impossible to give an exact prog­
nosis in the individual patient, but as a group it is 
probably fair to say that they have roughly a 
50 per cent chance o f surviving for 10 years. I f  
they already have experienced a myocardial 
infarction, i f  they have hypertension, cardiac 
enlargement or abnormal E C G  the prognosis is 
poorer. I f  they have no complication to their 
angina their chances o f surviving for 10 years are 
probably about 75 per cent. T h e prognosis is 
independent o f age, and severity and duration of 
the symptoms. It is better when the angina is 
combined with anaemia, obesitas or thyreotoxi­
cosis, while it is worse when it is combined with 
valvular heart disease. O n the whole the prog­
nosis o f angina pectoris is similar to the prognosis 
o f survivors o f myocardial infarction.
T he m ajority o f the patients have had angina 
pectoris for several years before the diagnosis was 
made. I f  we had been able to register the patients
from their first symptom this might have influenc­
ed the prognosis. It is, however, difficult to say in 
which way.
It is not impossible that cholesterol lowering 
diet and/or intensive anticoagulant therapy m ay 
improve the prognosis in patients with angina 
pectoris.
